NewsRx

Search our medical news database

Arthroplasty

Research from Korea University Provides New Data about Arthroplasty

Published in Medical Devices and Surgical Technology Week, January 15th, 2012

2012 JAN 15 -- "This study was conducted to analyze the clinical and radiographic results of isolated acetabular revisions during which intact femoral stems were retained. Twenty-nine hips of 26 patients who were followed up for a minimum of 3 years were examined," scientists in Seoul, South Korea report.

"The average time from primary operation to revision surgery was 9.2 years, and the average follow-up time after revision was 5 years. The average Harris hip scores improved from 56.4 to 89.8 points after revision surgery, and in all cases, the acetabular components and femoral stems were assessed as stable at the final follow-up. The average length of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook